Objective: To study the effectiveness of intratym‐panic dexamethasone (IT‐DEX) in patients
with severe or profound sudden sensorineural hearing loss (SSNHL) after treatment failure …

Objective: To compare the efficacy between one step with transient evoked otoacoustic
emissions (TEOAE) and two steps with TEOAE and automated auditory brainstem response (…

Voice control is an important way of controlling mobile devices; however, using it remains a
challenge for dysarthric patients. Currently, there are many approaches, such as automatic …

In mouse bone marrow primary cultures, the formation of osteoclast-like, ie tartrate-resistant
acid phosphatase (TRAP)- and calcitonin receptor-positive multinucleated cells (MNC), …

Objective Doctors, nowadays, primarily use auditory-perceptual evaluation, such as the
grade, roughness, breathiness, asthenia, and strain scale, to evaluate voice quality and …

Background Wolfram syndrome gene 1 (WFS1) accounts for most of the familial
nonsyndromic low-frequency sensorineural hearing loss (LFSNHL) which is characterized by …

1α,25-Dihydroxyvitamin D 3 and two synthetic analogs, 1α,25-dihydroxy-16-ene-23-yne-vitamin
D 3 (Ro 23-7553) and 1α,25-dihydroxy-16-ene-24-oxo-vitamin D 3 (JK-1624-3), were …

Objective To evaluate the concept and efficacy of an adjustable implant (Prototype SH30:
porcine implant and APrevent® VOIS: human concept) for treatment of unilateral vocal fold …

Formation of osteoclast-like cells in mouse bone marrow cultures induced by either 1,25-dihydroxyvitamin
D 3 (1,25-(OH) 2 D 3 ), parathyroid hormone (PTH) or prostaglandin E 2 (PGE …

Objectives/Hypothesis Evaluation of the clinical outcomes after 6 months of treatment with a
novel adjustable implant, the APrevent® Vocal‐Implant‐System (VOIS), in conjunction with …